Table 3.
Forty-eight-month Kaplan–Meier estimated cumulative incidence of main endpoints
S-ICD | TV-ICD | P-valuea | HR (CI) | |
---|---|---|---|---|
Device-related complications | 5.9% | 9.8% | 0.11 | 0.69 (0.44–1.09) |
Invasive interventions | 4.3% | 8.3% | 0.047 | 0.59 (0.35–0.99) |
Lead-related complications | 1.4% | 6.6% | < 0.001 | 0.24 (0.10–0.54) |
Systemic infections | 0 | 1.2% | 0.03 | – |
Acute complications | 3.8% | 4.7% | 0.49 | 0.79 (0.41–1.53) |
P-values were not adjusted for multiple comparisons.